Biaryl ether derivatives useful as monoamine reuptake inhibitors
US6596741B2 · kind B2 · utility
8Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2002 |
| Grant date | Jul 22, 2003 |
| Priority date | — |
| Expiry date | May 22, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I: and to their pharmaceutically acceptable salts. Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.